egtazic acid has been researched along with globotriaosylceramide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Capoulade, C; Carlier, K; Coulaud, D; Lécluse, Y; Mangeney, M; Mishal, Z; Pritchard, LL; Taga, S; Tétaud, C; Tursz, T; Wiels, J | 1 |
Huang, J; Liu, F; Sadler, JE | 1 |
2 other study(ies) available for egtazic acid and globotriaosylceramide
Article | Year |
---|---|
Intracellular signaling events in CD77-mediated apoptosis of Burkitt's lymphoma cells.
Topics: Apoptosis; Burkitt Lymphoma; Calcium; Calcium Channels; Ceramides; Chelating Agents; Colforsin; Cyclic AMP; Egtazic Acid; Humans; Ion Transport; Ionophores; Signal Transduction; Trihexosylceramides; Tumor Cells, Cultured | 1997 |
Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.
Topics: Animals; Calcium; Cyclic AMP-Dependent Protein Kinases; Diarrhea; Egtazic Acid; Endothelial Cells; Escherichia coli; Escherichia coli Infections; Gene Silencing; Hemolytic-Uremic Syndrome; Humans; Mice; Protein Binding; Protein Kinase C-alpha; Protein Kinase Inhibitors; RNA, Small Interfering; Shiga Toxin 1; Shiga Toxin 2; Signal Transduction; Trihexosylceramides; Umbilical Veins; von Willebrand Factor | 2011 |